[2-(PYRROLIDIN-1-YLMETHYL)PHENOXY]-ACETIC ACID HYDROCHLORIDE
- $184 - $779.63
- Product name: [2-(PYRROLIDIN-1-YLMETHYL)PHENOXY]-ACETIC ACID HYDROCHLORIDE
- CAS: 1185057-92-4
- MF: C13H18ClNO3
- MW: 271.74
- EINECS:
- MDL Number:MFCD06801276
- Synonyms:[2-(PYRROLIDIN-1-YLMETHYL)PHENOXY]-ACETIC ACID HYDROCHLORIDE
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500mg
- 5g
- ManufacturerAK Scientific
- Product number0117AD
- Product description[2-(Pyrrolidin-1-ylmethyl)phenoxy]-aceticacidhydrochloride
- Packaging500mg
- Price$298
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0081914
- Product description[2-(PYRROLIDIN-1-YLMETHYL)PHENOXY]-ACETIC ACID HYDROCHLORIDE 95.00%
- Packaging500MG
- Price$779.63
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11339016
- Product description2-(2-(Pyrrolidin-1-ylmethyl)phenoxy)aceticacidhydrochloride 97%
- Packaging5g
- Price$582
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number016415
- Product description[2-(Pyrrolidin-1-ylmethyl)phenoxy]-acetic acid hydrochloride
- Packaging500mg
- Price$184
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 0117AD | [2-(Pyrrolidin-1-ylmethyl)phenoxy]-aceticacidhydrochloride | 500mg | $298 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0081914 | [2-(PYRROLIDIN-1-YLMETHYL)PHENOXY]-ACETIC ACID HYDROCHLORIDE 95.00% | 500MG | $779.63 | 2021-12-16 | Buy |
Crysdot | CD11339016 | 2-(2-(Pyrrolidin-1-ylmethyl)phenoxy)aceticacidhydrochloride 97% | 5g | $582 | 2021-12-16 | Buy |
Matrix Scientific | 016415 | [2-(Pyrrolidin-1-ylmethyl)phenoxy]-acetic acid hydrochloride | 500mg | $184 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|